Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Barclays Maintains Overweight on XPO, Raises Price Target to $125

Author: Benzinga Newsdesk | February 08, 2024 04:29pm
Barclays analyst Brandon Oglenski maintains XPO (NYSE:XPO) with a Overweight and raises the price target from $100 to $125.

Posted In: XPO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist